Skip to content
Riskpilot
← Back to search
Sign in
Get full access
STIFTELSEN RENÅVANGEN
STI
Active
Org 956779510
Engerdalsveien 1222, 2485
Rendalen
Hospital activities
·
NACE 8610
Est. 1980 · 46 years old
40 employees
www.renavangen.no
Monitor
Share
Norway
/
Companies
/
Hospital activities
/
STIFTELSEN RENÅVANGEN
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
RS
Rigmor Sandodden Østby
Chief Executive Officer
Chief Executive Officer
2024
MY
Marit Ylva Sneltvedt
Deputy Member
Deputy Member
2022
Former (4)
MF
Maria Flottorp
Deputy Member
Deputy Member
2021 – 2022
SH
Sigbjørn Hagen
Deputy Member
Deputy Member
2022 – 2024
TA
Toril Andreassen
Chief Executive Officer
Chief Executive Officer
2014 – 2024
IN
Ivar Nordengen
Deputy Member
Deputy Member
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (9)
KL
Kristin Lervik
Board of Directors
Board of Directors
2022
MH
Mette Halvorsen Hornseth
Board of Directors
Board of Directors
2024
GS
Gaute Stubsveen
Board of Directors
Board of Directors
2025
JH
Jonny Haugseth
Deputy Chairman
Deputy Chairman
2022
PH
Patrick Henriksen
Board of Directors
Board of Directors
2022
NL
Nina Larsen Raaness
Board of Directors
Board of Directors
2025
WM
Weronica Mari Skarbø Kvammen
Board of Directors
Board of Directors
2022
MM
Marit Motrøen
Chairman
Chairman
2022
KB
Kim Bjørnar Hauge
Board of Directors
Board of Directors
2025
Former (4)
CS
Cisilie Selnes Westgaard
Chairman
Chairman
2021 – 2022
VM
Vegard Mømb
Board of Directors
Board of Directors
2022 – 2024
AG
Anne Grete Otnes
Board of Directors
Board of Directors
2021 – 2022
HJ
Hege Johnsen
Board of Directors
Board of Directors
2020 – 2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on STIFTELSEN RENÅVANGEN
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network